Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 117.11 USD 0.54% Market Closed
Market Cap: 635.9m USD

During the last 3 months Mesa Laboratories Inc insiders have not bought any shares, and sold 2.6m USD worth of shares. The stock price has dropped by 14% over this period (open performance analysis).

The last transaction was made on Mar 19, 2025 by Owens Gary M (Director) , who sold 2.6m USD worth of MLAB shares.

Last Transactions:
Owens Gary M
Director
$-2.6m
Owens Gary M
Director
$-285.7k
Archbold Brian David
Director
$-187.4k
Archbold Brian David
Director
$-168.5k
Schmieder John Bradley
Director and Chief Executive Officer
$-369.2k
Schmieder John Bradley
Director and Chief Executive Officer
$-370k
Owens Gary M
Director
$-285.6k
Sakys John
$-429.1k
Sakys John
Vice President of Continuous Improvement
$-165.7k
Sakys John
Vice President of Continuous Improvement
$-68k
Sakys John
Vice President of Continuous Improvement
$-184.3k
Sakys John
Vice President of Continuous Improvement
$-441.4k
Schmieder John Bradley
Director and Chief Executive Officer
$-300.5k
Schmieder John Bradley
Director and Chief Executive Officer
$-300.5k
Hall Shannon
General Manager of Clinical Microbiology
$-40.2k
Schmieder John Bradley
Director and Chief Executive Officer
$-438.6k
Guillemin Evan
Chief Financial Officer
$-724.1k
Sakys John
Vice President of Continuous Improvement
$-125.9k
Sakys John
Vice President of Continuous Improvement
$-125.9k
Tripeny R Tony
Chief Financial Officer
$+100k
Owens Gary M
Director
$-330.5k
Archbold Brian David
Director
$-73.8k
Dinoia Gregory
Chief Operating Officer and General Manager of Sterilization and Disinfection Business
$-104.5k
Sakys John
Vice President of Continuous Improvement
$-135.9k
Sullivan John James
Chief Financial Officer
$-1.1m
Sullivan John James
Chief Financial Officer
$-1.1m
Sakys John
Vice President of Continuous Improvement
$-18k
Sakys John
Vice President of Continuous Improvement
$-233.7k
Sullivan John James
Chief Financial Officer
$-1.3m
Schmieder John Bradley
Director and Chief Executive Officer
$-327.8k
Archbold Brian David
Director
$-539.2k
Sakys John
Vice President of Continuous Improvement
$-570.9k
View All Transactions

During the last 3 months Mesa Laboratories Inc insiders have not bought any shares, and sold 2.6m USD worth of shares. The stock price has dropped by 14% over this period (open performance analysis).

The last transaction was made on Mar 19, 2025 by Owens Gary M (Director) , who sold 2.6m USD worth of MLAB shares.

Sold
0-3
months
2.6m USD
1
3-6
months
0 USD
0
6-9
months
473k USD
2
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Mesa Laboratories Inc
Insider Trading Chart

Mesa Laboratories Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Mesa Laboratories Inc
Last Insider Transactions

Global
Insiders Monitor

Mesa Laboratories Inc
Glance View

Market Cap
636.3m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
97.9 USD
Overvaluation 16%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top